{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:53:59Z","timestamp":1777517639759,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40271-025-00792-0","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:10:40Z","timestamp":1764349840000},"page":"361-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient Preferences in Anticoagulation Treatment: A Review of Discrete Choice Experiments"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6829-2840","authenticated-orcid":false,"given":"Ilja M.","family":"Brugman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"van Eikenhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Schlinkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"792_CR1","unstructured":"World Health Organization. Medication safety in high-risk situations. Geneva: World Health Organization; 2019 (WHO\/UHC\/SDS\/2019.10). Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"6","key":"792_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/europace\/euab303","volume":"24","author":"M Grymonprez","year":"2021","unstructured":"Grymonprez M, et al. Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis. EP Europace. 2021;24(6):887\u201398.","journal-title":"EP Europace"},{"issue":"5","key":"792_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14042","volume":"75","author":"GYH Lip","year":"2021","unstructured":"Lip GYH, et al. Prevalence\/incidence of atrial fibrillation based on integrated medical\/pharmacy claims, and association with co-morbidity profiles\/multi-morbidity in a large US adult cohort. Int J Clin Pract. 2021;75(5):e14042.","journal-title":"Int J Clin Pract"},{"issue":"9","key":"792_CR4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340\u20137. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306841.","journal-title":"Circ Res"},{"issue":"11","key":"792_CR5","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.pec.2018.06.019","volume":"101","author":"MCW Vaanholt","year":"2018","unstructured":"Vaanholt MCW, Weernink MGM, von Birgelen C, Groothuis-Oudshoorn CGM, IJzerman MJ, van Til JA. Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen. Patient Educ Couns. 2018;101(11):1982\u20139. https:\/\/doi.org\/10.1016\/j.pec.2018.06.019.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"792_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/08870446.2015.1116534","volume":"31","author":"C Borg Xuereb","year":"2016","unstructured":"Borg Xuereb C, Shaw RL, Lane DA. Patients\u2019 and physicians\u2019 experiences of atrial fibrillation consultations and anticoagulation decision-making: a multi-perspective IPA design. Psychol Health. 2016;31(4):436\u201355.","journal-title":"Psychol Health"},{"issue":"1","key":"792_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40545-023-00563-y","volume":"16","author":"A Al Rowily","year":"2023","unstructured":"Al Rowily A, et al. Patients\u2019 views and experiences on the use and safety of directly acting oral anticoagulants: a qualitative study. J Pharm Policy Pract. 2023;16(1):58.","journal-title":"J Pharm Policy Pract"},{"issue":"2","key":"792_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4321\/S1886-36552009000200008","volume":"7","author":"BV Bajorek","year":"2009","unstructured":"Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Balancing risk versus benefit: the elderly patient\u2019s perspective on warfarin therapy. Pharm Pract (Granada). 2009;7(2):113\u201323. https:\/\/doi.org\/10.4321\/S1886-36552009000200008.","journal-title":"Pharm Pract (Granada)"},{"issue":"5","key":"792_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/1474515117739618","volume":"17","author":"B Bajorek","year":"2018","unstructured":"Bajorek B, et al. Patients\u2019 preferences for new versus old anticoagulants: a mixed-method vignette-based study. Eur J Cardiovasc Nurs. 2018;17(5):429\u201338.","journal-title":"Eur J Cardiovasc Nurs"},{"key":"792_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijnurstu.2018.07.013","volume":"88","author":"TR Pettersen","year":"2018","unstructured":"Pettersen TR, Fridlund B, Bendz B, Nordrehaug JE, Rotevatn S, Schj\u00f8tt J, et al. Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: a patient perspective. Int J Nurs Stud. 2018;88:16\u201324. https:\/\/doi.org\/10.1016\/j.ijnurstu.2018.07.013.","journal-title":"Int J Nurs Stud"},{"issue":"4","key":"792_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/a-1535-8726","volume":"122","author":"A van de Brug","year":"2022","unstructured":"van de Brug A, et al. Deciding on treatment duration for unprovoked venous thromboembolism: what is important to patients? Thromb Haemost. 2022;122(4):600\u201310.","journal-title":"Thromb Haemost"},{"issue":"9","key":"792_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257798","volume":"16","author":"A Holbrook","year":"2021","unstructured":"Holbrook A, et al. Barriers and facilitators for optimizing oral anticoagulant management: perspectives of patients, caregivers, and providers. PLoS ONE. 2021;16(9):e0257798.","journal-title":"PLoS ONE"},{"key":"792_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060839","author":"MJ Moesker","year":"2019","unstructured":"Moesker MJ, et al. Occurrence of antithrombotic related adverse events in hospitalized patients: incidence and clinical context between 2008 and 2016. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8060839.","journal-title":"J Clin Med"},{"key":"792_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/23743735211018066","volume":"8","author":"S Deniz","year":"2021","unstructured":"Deniz S, Akbolat M, \u00c7imen M, \u00dcnal \u00d6. The mediating role of shared decision-making in the effect of the patient-physician relationship on compliance with treatment. J Patient Exp. 2021;8:23743735211018066. https:\/\/doi.org\/10.1177\/23743735211018066.","journal-title":"J Patient Exp"},{"issue":"10","key":"792_CR15","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/CCM.0000000000002624","volume":"45","author":"MJ Goldfarb","year":"2017","unstructured":"Goldfarb MJ, Bibas L, Bartlett V, Jones H, Khan N. Outcomes of patient- and family-centered care interventions in the ICU: a systematic review and meta-analysis. Crit Care Med. 2017;45(10):1751\u201361. https:\/\/doi.org\/10.1097\/CCM.0000000000002624.","journal-title":"Crit Care Med"},{"key":"792_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/PPA.S292178","volume":"15","author":"Q Cao","year":"2021","unstructured":"Cao Q, et al. Investigating the influence of the shared decision-making perception on the patient adherence of the home- and exercise-based cardiac rehabilitation after percutaneous coronary intervention. Patient Prefer Adherence. 2021;15:411\u201322.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"792_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1377\/hlthaff.2012.1061","volume":"32","author":"JH Hibbard","year":"2013","unstructured":"Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff Millwood. 2013;32(2):207\u201314. https:\/\/doi.org\/10.1377\/hlthaff.2012.1061.","journal-title":"Health Aff Millwood"},{"key":"792_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2025.108789","volume":"137","author":"L Cariot","year":"2025","unstructured":"Cariot L, et al. Patient assertiveness and visit outcome in primary care: an observational study. Patient Educ Couns. 2025;137:108789.","journal-title":"Patient Educ Couns"},{"key":"792_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001570","author":"C Doyle","year":"2013","unstructured":"Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013. https:\/\/doi.org\/10.1136\/bmjopen-2012-001570.","journal-title":"BMJ Open"},{"issue":"2","key":"792_CR20","doi-asserted-by":"publisher","first-page":"bjgpopen18X1015","DOI":"10.3399\/bjgpopen18X101517","volume":"2","author":"ME Cupples","year":"2018","unstructured":"Cupples ME, et al. Shared decision-making (SHARE-D) for healthy behaviour change: a feasibility study in general practice. BJGP Open. 2018;2(2):bjgpopen18X101517.","journal-title":"BJGP Open"},{"issue":"2","key":"792_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1090198104263660","volume":"31","author":"A Bandura","year":"2004","unstructured":"Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143\u201364.","journal-title":"Health Educ Behav"},{"issue":"10","key":"792_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.pec.2015.06.022","volume":"98","author":"AM Stiggelbout","year":"2015","unstructured":"Stiggelbout AM, Pieterse AH, De Haes JCJM. Shared decision making: concepts, evidence, and practice. Patient Educ Couns. 2015;98(10):1172\u20139.","journal-title":"Patient Educ Couns"},{"issue":"7417","key":"792_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/bmj.327.7417.736","volume":"327","author":"AM O\u2019Connor","year":"2003","unstructured":"O\u2019Connor AM, L\u00e9gar\u00e9 F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ. 2003;327(7417):736\u201340.","journal-title":"BMJ"},{"key":"792_CR24","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.2147\/PPA.S279621","volume":"14","author":"HJ Mull","year":"2020","unstructured":"Mull HJ, Shin MH, Engle RL, Linsky AM, Kalver E, Lamkin R, et al. Veterans perceptions of satisfaction and convenience with anticoagulants for atrial fibrillation: warfarin versus direct oral anticoagulants. Patient Prefer Adherence. 2020;14:1911\u201322. https:\/\/doi.org\/10.2147\/PPA.S279621.","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"792_CR25","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1002\/nop2.964","volume":"9","author":"K Olsson","year":"2022","unstructured":"Olsson K, Hornsten A, Hellstrom Angerud K. Treated with preventive anticoagulation therapy in atrial fibrillation: the patients\u2019 perspective. Nurs Open. 2022;9(6):2657\u201364.","journal-title":"Nurs Open"},{"issue":"5","key":"792_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1586\/erp.09.48","volume":"9","author":"D Wild","year":"2009","unstructured":"Wild D, Murray M, Donatti C. Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain. Expert Rev Pharmacoecon Outcomes Res. 2009;9(5):467\u201374.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"792_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijnurstu.2009.05.021","volume":"47","author":"D Bolster","year":"2010","unstructured":"Bolster D, Manias E. Person-centred interactions between nurses and patients during medication activities in an acute hospital setting: qualitative observation and interview study. Int J Nurs Stud. 2010;47(2):154\u201365.","journal-title":"Int J Nurs Stud"},{"issue":"11-12","key":"792_CR28","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1111\/jocn.15024","volume":"29","author":"E van Belle","year":"2020","unstructured":"van Belle E, Giesen J, Conroy T, van Mierlo M, Vermeulen H, de Huisman\u2010 Waal G, et al. Exploring person-centred fundamental nursing care in hospital wards: a multi-site ethnography. J Clin Nurs. 2020;29(11\u201312):1933\u201344. https:\/\/doi.org\/10.1111\/jocn.15024.","journal-title":"J Clin Nurs"},{"key":"792_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jss.2022.03.009","volume":"276","author":"M Javaid","year":"2022","unstructured":"Javaid M, et al. Use and perceptions of shared decision-making by general surgery faculty and trainees. J Surg Res. 2022;276:323\u201330.","journal-title":"J Surg Res"},{"issue":"8","key":"792_CR30","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.pec.2022.03.025","volume":"105","author":"EM Driever","year":"2022","unstructured":"Driever EM, Stiggelbout AM, Brand PLP. Patients\u2019 preferred and perceived decision-making roles, and observed patient involvement in videotaped encounters with medical specialists. Patient Educ Couns. 2022;105(8):2702\u20137. https:\/\/doi.org\/10.1016\/j.pec.2022.03.025.","journal-title":"Patient Educ Couns"},{"issue":"8","key":"792_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.sapharm.2023.05.008","volume":"19","author":"LM van Dijk","year":"2023","unstructured":"van Dijk LM, van Eikenhorst L, Karapinar-\u00c7arkit F, Wagner C. Patient participation during discharge medication counselling: observing real-life communication between healthcare professionals and patients. Res Social Adm Pharm. 2023;19(8):1228\u201335. https:\/\/doi.org\/10.1016\/j.sapharm.2023.05.008.","journal-title":"Res Social Adm Pharm"},{"issue":"8","key":"792_CR32","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11606-009-0987-8","volume":"24","author":"CA Chong","year":"2009","unstructured":"Chong CA, et al. How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med. 2009;24(8):977\u201382.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"792_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jama.300.4.436","volume":"300","author":"M Krahn","year":"2008","unstructured":"Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. JAMA. 2008;300(4):436\u20138.","journal-title":"JAMA"},{"issue":"4","key":"792_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/ehjqcco\/qcaa040","volume":"6","author":"F Ali-Ahmed","year":"2020","unstructured":"Ali-Ahmed F, et al. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. Eur Heart J Qual Care Clin Outcomes. 2020;6(4):263\u201372.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"4","key":"792_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/1474515118812252","volume":"18","author":"SD Pokorney","year":"2019","unstructured":"Pokorney SD, Bloom D, Granger CB, Thomas KL, Al-Khatib SM, Roettig ML, et al. Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: results of the INFORM-AF study. Eur J Cardiovasc Nurs. 2019;18(4):280\u20138. https:\/\/doi.org\/10.1177\/1474515118812252.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"4","key":"792_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JF Bridges","year":"2011","unstructured":"Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403\u201313. https:\/\/doi.org\/10.1016\/j.jval.2010.11.013.","journal-title":"Value Health"},{"issue":"1","key":"792_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12875-016-0574-0","volume":"18","author":"G Mas Dalmau","year":"2017","unstructured":"Mas Dalmau G, et al. Patients\u2019 and physicians\u2019 perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. BMC Fam Pract. 2017;18(1):3.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"792_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40271-016-0185-9","volume":"10","author":"T Wilke","year":"2017","unstructured":"Wilke T, et al. Patient preferences for oral anticoagulation therapy in atrial fibrillation: a systematic literature review. Patient. 2017;10(1):17\u201337.","journal-title":"Patient"},{"issue":"1","key":"792_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12875-021-01590-x","volume":"22","author":"YM Osasu","year":"2021","unstructured":"Osasu YM, Cooper R, Mitchell C. Patients\u2019 and clinicians\u2019 perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis. BMC Fam Pract. 2021;22(1):254.","journal-title":"BMC Fam Pract"},{"issue":"2","key":"792_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pec.2012.05.011","volume":"88","author":"C Borg Xuereb","year":"2012","unstructured":"Borg Xuereb C, Shaw RL, Lane DA. Patients\u2019 and health professionals\u2019 views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. Patient Educ Couns. 2012;88(2):330\u20137.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"792_CR41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1185\/030079908X297349","volume":"24","author":"G Dolan","year":"2008","unstructured":"Dolan G, et al. Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature. Curr Med Res Opin. 2008;24(5):1459\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"792_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300\u201315.","journal-title":"Value Health"},{"key":"792_CR43","unstructured":"Health Council of the Netherlands. New Anticoagulants: A well-dosed introduction. The Hague: Health Council of the\nNetherlands, 2012; publication no. 2012\/07."},{"issue":"1","key":"792_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, et al. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"792_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"792_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1472-6963-14-367","volume":"14","author":"KL Mandeville","year":"2014","unstructured":"Mandeville KL, Lagarde M, Hanson K. The use of discrete choice experiments to inform health workforce policy: a systematic review. BMC Health Serv Res. 2014;14:367.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"792_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11239-015-1263-x","volume":"40","author":"B B\u00f6ttger","year":"2015","unstructured":"B\u00f6ttger B, et al. Preferences for anticoagulation therapy in atrial fibrillation: the patients\u2019 view. J Thromb Thrombolysis. 2015;40(4):406\u201315.","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"792_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016676","volume":"7","author":"BE Haac","year":"2017","unstructured":"Haac BE, O\u2019Hara NN, Mullins CD, Stein DM, Manson TT, Johal H, et al. Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment. BMJ Open. 2017;7(8):e016676. https:\/\/doi.org\/10.1136\/bmjopen-2017-016676.","journal-title":"BMJ Open"},{"issue":"1","key":"792_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/FJC.0000000000000936","volume":"77","author":"M Henry","year":"2021","unstructured":"Henry M, et al. Country-based comparison of atrial fibrillation patients\u2019 preferences for oral anticoagulation: an evaluation of discrete choice experiments in five different countries. J Cardiovasc Pharmacol. 2021;77(1):100\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"792_CR50","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/CIRCOUTCOMES.114.001013","volume":"7","author":"M Najafzadeh","year":"2014","unstructured":"Najafzadeh M, et al. Patients\u2019 preferences in anticoagulant therapy: discrete choice experiment. Circ Cardiovasc Qual Outcomes. 2014;7(6):912\u20139.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"792_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.vhri.2015.03.016","volume":"6","author":"K Okumura","year":"2015","unstructured":"Okumura K, et al. Comparing patient and physician risk tolerance for bleeding events associated with anticoagulants in atrial fibrillation-evidence from the United States and Japan. Value Health Reg Issues. 2015;6:65\u201372.","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"792_CR52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jval.2016.01.001","volume":"19","author":"J Shafrin","year":"2016","unstructured":"Shafrin J, et al. Physician and patient preferences for nonvalvular atrial fibrillation therapies. Value Health. 2016;19(4):451\u20139.","journal-title":"Value Health"},{"key":"792_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5719624","volume":"2019","author":"T Wilke","year":"2019","unstructured":"Wilke T, Meinecke A-K, Schaefer B, Buchwald S, Eriksson D, M\u00fcller S. Patient preferences for nonvitamin K antagonist oral anticoagulants in stroke prevention: a multicountry discrete choice experiment. Cardiol Res Pract. 2019;2019:5719624. https:\/\/doi.org\/10.1155\/2019\/5719624.","journal-title":"Cardiol Res Pract"},{"issue":"8","key":"792_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003730","volume":"18","author":"J Zhao","year":"2021","unstructured":"Zhao J, et al. Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: a discrete choice experiment. PLoS Med. 2021;18(8):e1003730.","journal-title":"PLoS Med"},{"key":"792_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2025.103084","volume":"54","author":"R Wang","year":"2025","unstructured":"Wang R, et al. Patient preferences for stroke prevention treatments in atrial fibrillation in Asia: a discrete choice experiment. Prev Med Rep. 2025;54:103084.","journal-title":"Prev Med Rep"},{"issue":"11","key":"792_CR56","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s40273-014-0188-0","volume":"32","author":"P Ghijben","year":"2014","unstructured":"Ghijben P, Lancsar E, Zavarsek S. Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment. Pharmacoeconomics. 2014;32(11):1115\u201327.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"792_CR57","doi-asserted-by":"publisher","first-page":"207","DOI":"10.36469\/9904","volume":"2","author":"K Okumura","year":"2015","unstructured":"Okumura K, et al. Japanese patients\u2019 and physicians\u2019 preferences for anticoagulant use in atrial fibrillation: results from a discrete-choice experiment. J Health Econ Outcomes Res. 2015;2(2):207\u201320.","journal-title":"J Health Econ Outcomes Res"},{"issue":"3","key":"792_CR58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11739-012-0844-3","volume":"8","author":"M Moia","year":"2013","unstructured":"Moia M, et al. Patient preferences and willingness to pay for different options of anticoagulant therapy. Intern Emerg Med. 2013;8(3):237\u201343.","journal-title":"Intern Emerg Med"},{"issue":"2","key":"792_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40271-018-0329-1","volume":"12","author":"M Najafzadeh","year":"2019","unstructured":"Najafzadeh M, et al. General population vs. patient preferences in anticoagulant therapy: a discrete choice experiment. Patient. 2019;12(2):235\u201346.","journal-title":"Patient"},{"key":"792_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11050153","author":"EA Gebreyohannes","year":"2023","unstructured":"Gebreyohannes EA, et al. Patients\u2019 perspectives on commencing oral anticoagulants in atrial fibrillation: an exploratory qualitative descriptive study. Pharmacy. 2023. https:\/\/doi.org\/10.3390\/pharmacy11050153.","journal-title":"Pharmacy"},{"issue":"23\u201324","key":"792_CR61","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1111\/jocn.13759","volume":"26","author":"C Ferguson","year":"2017","unstructured":"Ferguson C, et al. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives. J Clin Nurs. 2017;26(23\u201324):4325\u201334.","journal-title":"J Clin Nurs"},{"key":"792_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jth.2024.101819","volume":"37","author":"EP Mseke","year":"2024","unstructured":"Mseke EP, Jessup B, Barnett T. Impact of distance and\/or travel time on healthcare service access in rural and remote areas: a scoping review. J Transp Health. 2024;37:101819. https:\/\/doi.org\/10.1016\/j.jth.2024.101819.","journal-title":"J Transp Health"},{"key":"792_CR63","unstructured":"World Health Organization. Medication without harm: policy brief. Geneva: World Health Organization; 2023. Licence: CC BYNC-\nSA 3.0 IGO."},{"issue":"8","key":"792_CR64","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0277-9536(03)00349-6","volume":"58","author":"J Siegrist","year":"2004","unstructured":"Siegrist J, Marmot M. Health inequalities and the psychosocial environment\u2014two scientific challenges. Soc Sci Med. 2004;58(8):1463\u201373.","journal-title":"Soc Sci Med"},{"issue":"7","key":"792_CR65","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMsa044316","volume":"355","author":"M Minkler","year":"2006","unstructured":"Minkler M, Fuller-Thomson E, Guralnik JM. Gradient of disability across the socioeconomic spectrum in the United States. N Engl J Med. 2006;355(7):695\u2013703.","journal-title":"N Engl J Med"},{"issue":"12","key":"792_CR66","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/jamainternmed.2017.3903","volume":"177","author":"LK Makaroun","year":"2017","unstructured":"Makaroun LK, et al. Wealth-associated disparities in death and disability in the United States and England. JAMA Intern Med. 2017;177(12):1745\u201353.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"792_CR67","doi-asserted-by":"publisher","first-page":"351","DOI":"10.18553\/jmcp.2012.18.5.351","volume":"18","author":"TM Brown","year":"2012","unstructured":"Brown TM, Siu K, Walker D, Pladevall-Vila M, Sander S, Mordin M. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. J Manag Care Pharm. 2012;18(5):351\u201362. https:\/\/doi.org\/10.18553\/jmcp.2012.18.5.351.","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"792_CR68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/eurjcn\/zvab085","volume":"21","author":"D Song","year":"2022","unstructured":"Song D, et al. Decision aids for shared decision-making and appropriate anticoagulation therapy in patients with atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Nurs. 2022;21(2):97\u2013106.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"1","key":"792_CR69","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.4022\/jafib.1579","volume":"10","author":"R Sheibani","year":"2017","unstructured":"Sheibani R, et al. Effects of computerized decision support systems on management of atrial fibrillation: a scoping review. J Atr Fibrillation. 2017;10(1):1579.","journal-title":"J Atr Fibrillation"},{"key":"792_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2017.05.014","volume":"191","author":"ES O\u2019Neill","year":"2017","unstructured":"O\u2019Neill ES, et al. Availability of patient decision aids for stroke prevention in atrial fibrillation: a systematic review. Am Heart J. 2017;191:1\u201311.","journal-title":"Am Heart J"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-025-00792-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-025-00792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:03:11Z","timestamp":1777392191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-025-00792-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s40271-025-00792-0","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"During the preparation of this work the author(s) used ChatGPT (version January 2025) in order to improve the readability and language of the text. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process"}},{"value":"Ilja M. Brugman: conceptualization, formal analysis, methodology, visualization, writing\u2014original draft, writing\u2014review and editing. Linda van Eikenhorst: conceptualization, funding acquisition, formal analysis, methodology, supervision, writing\u2014review and editing. Caroline Schlinkert: conceptualization, supervision, writing\u2014review and editing. Cordula Wagner: conceptualization, supervision, writing\u2014review and editing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"We did not analyse or generate any datasets, because this article is a review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}